ESC Professional Premium Access

Neprilysin inhibition: news and nuggets

Event: ESC Congress 2022
Topic: Treatment
Session type: Abstract Sessions
Date: 29 August 2022
Time: 15:30 - 16:30

Congress Session

Become an ESC Professional member to access this resource

Become a member

Already a member? Sign in

6 presentations in this session

Effects of sacubitril-valsartan on clinical, echocardiographic and polygraphic parameters in patients affected by heart failure with reduced ejection fraction and sleep apnea

Speaker: Doctor G. Armentaro (Catanzaro, IT)
Thumbnail

Sacubitril/valsartan compared to ramipril in high risk post myocardial infarction patients stratified according use of mineralocorticoid receptor antagonists: Insight from PARADISE MI trial

Speaker: Professor M. Schou (Herlev-Gentofte, DK)
Thumbnail

ARNI effects in HFrEF. Risk reduction beyond LVEF

Speaker: Doctor A. Boehmer (Wiesbaden, DE)
Thumbnail

Prevalent and incident anaemia in PARADIGM-HF and effect of sacubitril/valsartan

Speaker: Doctor J. Curtain (Glasgow, GB)
Thumbnail

Effects of angiotensin receptor-neprilysin inhibitors (ARNIs) on the glucose and fat metabolism biomarkers leptin and fructosamin

Speaker: Doctor B. Ohnewein (Salzburg, AT)
Thumbnail

Effect of sacubitril/valsartan on endothelial dysfunction and arterial stiffness in patients with chronic heart failure

Speaker: Doctor V. Cassano (Catanzaro, IT)
Thumbnail

6 speakers from this session

Doctor Giuseppe Armentaro

Magna Graecia University of Catanzaro, Catanzaro (Italy)
0 follower

Professor Morten Schou

Herlev-Gentofte Hospital (University of Copenhagen), Herlev-Gentofte (Denmark)
1 presentation
0 follower

Doctor Andreas Alexandre Boehmer

St. Josefs- Hospital Wiesbaden, Wiesbaden (Germany)
0 follower

Doctor James Curtain

Cardiovascular Research Centre of Glasgow, Glasgow (United Kingdom of Great Britain & Northern Ireland)
1 presentation
0 follower

Doctor Bernhard Ohnewein

Paracelsus Private Medical University, Salzburg (Austria)
0 follower

Doctor Velia Cassano

Magna Graecia University of Catanzaro, Catanzaro (Italy)
0 follower

This platform is supported by

logo Novo Nordisk